Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_assertion description "[In total, 82 patients with CML who had been administered 400 mg IM daily for over 6 months were genotyped for 11 single-nucleotide polymorphisms in nine genes (CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6, ABCB1, SLC22A1, SLC22A2 and ABCG2) using blood samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_assertion evidence source_evidence_literature NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_assertion SIO_000772 23117072 NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_assertion wasDerivedFrom befree-2016 NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_assertion wasGeneratedBy ECO_0000203 NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1025368.RA_U9HCzGEjS0K1u1YJnvPPQHVpOJxx0zabmaTVke0yuI130_provenance.